Thiazolopyridine derivatives as adenosine receptor antagonists
US12344623B2 · kind B2 · utility
0Cited by
5References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2020 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Jul 2, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to thiazolopyridine derivatives which fall under the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.